Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gender differences in drug therapy.

S Khosla1, J C Somberg

  • 1Department of Medicine and Clinical Pharmacology, University of Health Sciences, The Chicago Medical School, 3333 Green Bay Road, North Chicago, IL USA.

American Journal of Therapeutics
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Women's Musculoskeletal Health: Insights from the 2024 National Academies of Sciences, Engineering, and Medicine Report on Chronic Conditions.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023
Same author

Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
Same author

Peri-operative complications of sphenopalatine artery ligation: a 10-year series from two secondary care centres.

The Journal of laryngology and otology·2022
Same author

1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.

Neuromuscular disorders : NMD·2021
Same author

Ex vivo normothermic perfusion of isolated segmental porcine bowel: a novel functional model of the small intestine.

BJS open·2021

Gender significantly impacts drug response and side effects due to physiological and hormonal differences. Understanding these pharmacotherapy variations is crucial for effective patient treatment, especially for women often underrepresented in clinical trials.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Gender Studies in Medicine

Background:

  • Patient response to drug therapy is influenced by numerous factors, including age, renal function, diet, smoking, heart failure, and gender.
  • Limited data exist on gender differences in pharmacotherapy, partly due to women's exclusion from clinical research.
  • Existing information highlights gender-based variations in drug distribution, response, metabolism, and side effects.

Purpose of the Study:

  • To review and highlight the known gender differences in pharmacotherapy.
  • To emphasize the importance of considering gender-specific factors in drug prescribing.
  • To underscore the need for more inclusive clinical research.

Main Methods:

  • Literature review of existing studies on gender differences in drug therapy.

Related Experiment Videos

  • Analysis of documented physiological, hormonal, and metabolic variations between genders affecting drug action.
  • Examination of clinical examples illustrating gender-specific drug efficacy and side effect profiles.

    • Main Results:

    • Gender influences drug distribution, response, and metabolism through factors like body composition and hormonal differences.
    • Enzyme concentrations (e.g., alcohol dehydrogenase) can differ, affecting drug metabolism.
    • Disease expression (e.g., vasomotor tone) and drug efficacy (e.g., antiplatelet therapy) vary by gender.
    • Drug side effects can also present differently between genders.

    Conclusions:

    • Healthcare providers must be aware of gender-specific differences when prescribing medications.
    • Pharmacotherapy may require adjustments based on a patient's gender.
    • The current body of pharmaceutical data, largely derived from male populations, necessitates a greater focus on female-specific responses.